MoneyWorks4Me

Coral Laboratories - Quaterly Results

23 May 2024 Evaluate
The Total revenue for the quarter ended March 2024 of  Rs. 288.86 millions grew by 152.54% from Rs. 114.38 millions.The Total Profit for the quarter ended March 2024 of Rs. 57.87 millions grew from Rs.-8.93 millions Operating profit Margin for the quarter ended March 2024 improved to 83.39% as compared to -9.24% of corresponding quarter ended March 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 288.86 114.38 152.54 836.60 781.18 7.09 836.60 781.18 7.09
Other Income 20.92 11.61 80.19 66.32 68.95 -3.81 66.32 68.95 -3.81
PBIDT 83.39 -9.24 -1002.49 228.71 107.07 113.61 228.71 107.07 113.61
Interest 0.00 0.18 -100.00 0.00 3.38 -100.00 0.00 3.38 -100.00
PBDT 82.48 -9.42 -975.58 227.07 104.07 118.19 227.07 104.07 118.19
Depreciation 5.03 6.80 -26.03 19.76 21.80 -9.36 19.76 21.80 -9.36
PBT 77.45 -16.22 -577.50 207.31 82.27 151.99 207.31 82.27 151.99
TAX 19.58 -7.29 -368.59 49.43 17.81 177.54 49.43 17.81 177.54
Deferred Tax -0.26 -0.99 -73.74 0.34 -0.39 -187.18 0.34 -0.39 -187.18
PAT 57.87 -8.93 -748.04 157.88 64.46 144.93 157.88 64.46 144.93
Equity 35.73 35.73 0.00 35.73 35.73 0.00 35.73 35.73 0.00
PBIDTM(%) 28.87 -8.08 -457.36 27.34 13.71 99.46 27.34 13.71 99.46
Peers
Company Name CMP
Sun Pharma. Inds. 1850.10
Dr. Reddys Labs. 1201.85
Cipla 1400.20
Lupin 2095.40
Zydus Lifesciences 1187.95
View more..